39 related articles for article (PubMed ID: 22364609)
1. Circular RNA 0001789 sponges miR-140-3p and regulates PAK2 to promote the progression of gastric cancer.
You J; Chen Y; Chen D; Li Y; Wang T; Zhu J; Hong Q; Li Q
J Transl Med; 2023 Feb; 21(1):83. PubMed ID: 36740679
[TBL] [Abstract][Full Text] [Related]
2. p21-Activated Kinase: Role in Gastrointestinal Cancer and Beyond.
Li X; Li F
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230657
[TBL] [Abstract][Full Text] [Related]
3. RhoGDI2 induced malignant phenotypes of pancreatic cancer cells via regulating Snail expression.
Yi B; Hu Y; Zhu D; Yao J; Zhou J; Zhang Y; He Z; Zhang L; Zhang Z; Yang J; Tang Y; Huang Y; Li D; Liu Q
Genes Genomics; 2022 May; 44(5):561-569. PubMed ID: 35147897
[TBL] [Abstract][Full Text] [Related]
4. miR-511-5p Suppresses Cell Migration, Invasion and Epithelial-Mesenchymal Transition Through Targeting PAK2 in Gastric Cancer.
Yong W; Zhang K; Deng Y; Tang W; Tao R
Biochem Genet; 2022 Jun; 60(3):899-913. PubMed ID: 34542739
[TBL] [Abstract][Full Text] [Related]
5. Serum Levels of Cytokine-Induced Apoptosis Inhibitor 1 (CIAPIN1) as a Potential Prognostic Biomarker of Cholangiocarcinoma.
Truong SDA; Tummanatsakun D; Proungvitaya T; Limpaiboon T; Wongwattanakul M; Chua-On D; Roytrakul S; Proungvitaya S
Diagnostics (Basel); 2021 Jun; 11(6):. PubMed ID: 34201138
[TBL] [Abstract][Full Text] [Related]
6. Long intergenic noncoding RNA 00665 promotes proliferation and inhibits apoptosis in colorectal cancer by regulating miR-126-5p.
Wu CL; Shan TD; Han Y; Kong Y; Li YB; Peng XG; Shang L; Wang PG; Li LP
Aging (Albany NY); 2021 Apr; 13(10):13571-13584. PubMed ID: 33878735
[TBL] [Abstract][Full Text] [Related]
7. Nujiangexanthone A Inhibits Hepatocellular Carcinoma Metastasis via Down Regulation of Cofilin 1.
Zhang L; Chai Z; Kong S; Feng J; Wu M; Tan J; Yuan M; Chen G; Li Z; Zhou H; Cheng S; Xu H
Front Cell Dev Biol; 2021; 9():644716. PubMed ID: 33791303
[TBL] [Abstract][Full Text] [Related]
8. Progesterone receptor membrane component 1 is involved in oral cancer cell metastasis.
Huang HY; Chou HC; Law CH; Chang WT; Wen TN; Liao EC; Lin MW; Lin LH; Wei YS; Tsai YT; Chen HY; Tan KT; Kuo WH; Ko ML; Chang SJ; Lee YR; Chan HL
J Cell Mol Med; 2020 Sep; 24(17):9737-9751. PubMed ID: 32672400
[TBL] [Abstract][Full Text] [Related]
9. CDK12 and PAK2 as novel therapeutic targets for human gastric cancer.
Liu H; Shin SH; Chen H; Liu T; Li Z; Hu Y; Liu F; Zhang C; Kim DJ; Liu K; Dong Z
Theranostics; 2020; 10(14):6201-6215. PubMed ID: 32483448
[No Abstract] [Full Text] [Related]
10.
Wang H; Gu H; Feng J; Qian Y; Yang L; Jin F; Wang X; Chen J; Shi Y; Lu S; Zhao M; Liu Y
Oncol Lett; 2017 Sep; 14(3):2926-2932. PubMed ID: 28927046
[No Abstract] [Full Text] [Related]
11. Cofilin 1 induces the epithelial-mesenchymal transition of gastric cancer cells by promoting cytoskeletal rearrangement.
Wang H; Tao L; Jin F; Gu H; Dai X; Ni T; Feng J; Ding Y; Xiao W; Qian Y; Liu Y
Oncotarget; 2017 Jun; 8(24):39131-39142. PubMed ID: 28388575
[TBL] [Abstract][Full Text] [Related]
12. The dynamics of Rho GTPase signaling and implications for targeting cancer and the tumor microenvironment.
Pajic M; Herrmann D; Vennin C; Conway JR; Chin VT; Johnsson AK; Welch HC; Timpson P
Small GTPases; 2015; 6(2):123-33. PubMed ID: 26103062
[TBL] [Abstract][Full Text] [Related]
13. RhoGDI2 promotes epithelial-mesenchymal transition via induction of Snail in gastric cancer cells.
Cho HJ; Park SM; Kim IK; Nam IK; Baek KE; Im MJ; Yoo JM; Park SH; Ryu KJ; Han HT; Kim HJ; Hong SC; Kim KD; Pak Y; Kim JW; Lee CW; Yoo J
Oncotarget; 2014 Mar; 5(6):1554-64. PubMed ID: 24721928
[TBL] [Abstract][Full Text] [Related]
14. Identification of reproducible gene expression signatures in lung adenocarcinoma.
Lu TP; Chuang EY; Chen JJ
BMC Bioinformatics; 2013 Dec; 14():371. PubMed ID: 24369726
[TBL] [Abstract][Full Text] [Related]
15. 14-3-3σ attenuates RhoGDI2-induced cisplatin resistance through activation of Erk and p38 in gastric cancer cells.
Kim IK; Park SM; Cho HJ; Baek KE; Nam IK; Park SH; Ryu KJ; Ryu J; Choi J; Hong SC; Kim JW; Lee CW; Kang SS; Yoo J
Oncotarget; 2013 Nov; 4(11):2045-56. PubMed ID: 24185104
[TBL] [Abstract][Full Text] [Related]
16. Proteomics-based strategy to delineate the molecular mechanisms of RhoGDI2-induced metastasis and drug resistance in gastric cancer.
Cho HJ; Baek KE; Kim IK; Park SM; Choi YL; Nam IK; Park SH; Im MJ; Yoo JM; Ryu KJ; Oh YT; Hong SC; Kwon OH; Kim JW; Lee CW; Yoo J
J Proteome Res; 2012 Apr; 11(4):2355-64. PubMed ID: 22364609
[TBL] [Abstract][Full Text] [Related]
17. RhoGDI2 confers gastric cancer cells resistance against cisplatin-induced apoptosis by upregulation of Bcl-2 expression.
Cho HJ; Baek KE; Park SM; Kim IK; Nam IK; Choi YL; Park SH; Im MJ; Choi J; Ryu J; Kim JW; Lee CW; Kang SS; Yoo J
Cancer Lett; 2011 Dec; 311(1):48-56. PubMed ID: 21752536
[TBL] [Abstract][Full Text] [Related]
18. PLCγ is required for RhoGDI2-mediated cisplatin resistance in gastric cancer.
Cho HJ; Baek KE; Nam IK; Park SM; Kim IK; Park SH; Im MJ; Ryu KJ; Yoo JM; Hong SC; Kim JW; Lee CW; Yoo J
Biochem Biophys Res Commun; 2011 Oct; 414(3):575-80. PubMed ID: 21986528
[TBL] [Abstract][Full Text] [Related]
19. RhoGDI2 expression is associated with tumor growth and malignant progression of gastric cancer.
Cho HJ; Baek KE; Park SM; Kim IK; Choi YL; Cho HJ; Nam IK; Hwang EM; Park JY; Han JY; Kang SS; Kim DC; Lee WS; Lee MN; Oh GT; Kim JW; Lee CW; Yoo J
Clin Cancer Res; 2009 Apr; 15(8):2612-9. PubMed ID: 19351766
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
